Search research articles
Contact Us
Filters
Showing results (141-150 of 147) with videos related to
Page
of 15
Sort By:
You have reached the last page of results.
This site can display upto 147 results.
Blood Advances
|
February 11, 2026
ASH 2026 Guidelines for Management of Relapsed/Refractory Disease in Adolescents and Young Adults with ALL
Kristen M O'Dwyer, Lena E Winestone, Matthew C Cheung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 31, 2026
Structured exercise program following adjuvant chemotherapy for colon cancer: A cost-utility analysis of the CHALLENGE trial
Kelvin Kw Chan, Ryan Wk Chu, Matthew C Cheung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 23, 2019
Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma
Anas Younes, Laurie H Sehn, Peter Johnson, et al.
The New England Journal of Medicine
|
December 14, 2021
Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma
Hervé Tilly, Franck Morschhauser, Laurie H Sehn, et al.
Blood Advances
|
February 11, 2026
ASH 2026 Guidelines for Frontline Management of Acute Lymphoblastic Leukemia in Adolescents and Young Adults
Adam S DuVall, Jennifer McNeer, Matthew C Cheung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 20, 2025
Erratum: Five-Year Outcomes of the POLARIX Study Comparing Pola-R-CHP and R-CHOP in Patients With Diffuse Large B-Cell Lymphoma
Franck Morschhauser, Gilles Salles, Laurie H Sehn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 24, 2025
Five-Year Outcomes of the POLARIX Study Comparing Pola-R-CHP and R-CHOP in Patients With Diffuse Large B-Cell Lymphoma
Franck Morschhauser, Gilles Salles, Laurie H Sehn, et al.
Page
of 15
Search research articles
Search
Showing results (141-150 of 147) with videos related to
Sort By:
Page
of 15
You have reached the last page of results.
This site can display upto 147 results.
Blood Advances
|
February 11, 2026
ASH 2026 Guidelines for Management of Relapsed/Refractory Disease in Adolescents and Young Adults with ALL
Kristen M O'Dwyer, Lena E Winestone, Matthew C Cheung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 31, 2026
Structured exercise program following adjuvant chemotherapy for colon cancer: A cost-utility analysis of the CHALLENGE trial
Kelvin Kw Chan, Ryan Wk Chu, Matthew C Cheung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 23, 2019
Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma
Anas Younes, Laurie H Sehn, Peter Johnson, et al.
The New England Journal of Medicine
|
December 14, 2021
Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma
Hervé Tilly, Franck Morschhauser, Laurie H Sehn, et al.
Blood Advances
|
February 11, 2026
ASH 2026 Guidelines for Frontline Management of Acute Lymphoblastic Leukemia in Adolescents and Young Adults
Adam S DuVall, Jennifer McNeer, Matthew C Cheung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 20, 2025
Erratum: Five-Year Outcomes of the POLARIX Study Comparing Pola-R-CHP and R-CHOP in Patients With Diffuse Large B-Cell Lymphoma
Franck Morschhauser, Gilles Salles, Laurie H Sehn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 24, 2025
Five-Year Outcomes of the POLARIX Study Comparing Pola-R-CHP and R-CHOP in Patients With Diffuse Large B-Cell Lymphoma
Franck Morschhauser, Gilles Salles, Laurie H Sehn, et al.
Page
of 15